Arcus Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NYSE:RCUS Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
27 Feb 25	BuyUS$201,465	Terry Rosen	Individual	19,800	US$10.18
27 Feb 25	BuyUS$201,200	Yasunori Kaneko	Individual	20,000	US$10.06
18 Feb 25	BuyUS$14,999,996	Gilead Sciences, Inc.	Company	1,363,636	US$11.00

Insider Trading Volume

Insider Buying: RCUS insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of RCUS?
Owner Type	Number of Shares	Ownership Percentage
State or Government	24,781	0.0234%
Private Companies	4,191,444	3.96%
Individual Insiders	4,627,783	4.37%
General Public	10,761,136	10.2%
Public Companies	31,424,760	29.7%
Institutions	54,855,234	51.8%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 16.4%.

Top Shareholders

Top 25 shareholders own 78.12% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
29.7%	Gilead Sciences, Inc.	31,424,760	US$286.6m	4.54%	no data
9.42%	BlackRock, Inc.	9,977,061	US$91.0m	2.92%	no data
5.09%	The Vanguard Group, Inc.	5,389,216	US$49.1m	-1.45%	no data
3.83%	FMR LLC	4,052,521	US$37.0m	-9.29%	no data
3.33%	Woodline Partners LP	3,523,937	US$32.1m	1.31%	0.23%
3.24%	Rosen Family Trust	3,433,870	US$31.3m	0%	no data
2.83%	State Street Global Advisors, Inc.	2,993,729	US$27.3m	-0.58%	no data
2.43%	Terry Rosen	2,571,357	US$23.5m	-10.1%	no data
2.12%	Point72 Asset Management, L.P.	2,239,964	US$20.4m	-11.6%	0.05%
1.61%	Dimensional Fund Advisors LP	1,702,302	US$15.5m	11.7%	no data
1.52%	Invus Financial Advisors, LLC	1,612,077	US$14.7m	0%	0.77%
1.51%	Boxer Capital Management, LLC	1,602,200	US$14.6m	0%	1.33%
1.46%	Columbia Management Investment Advisers, LLC	1,547,591	US$14.1m	17.3%	no data
1.44%	BNPP Asset Management Holding	1,521,784	US$13.9m	63.5%	0.02%
1.36%	Juan Jaen	1,444,741	US$13.2m	0.34%	no data
1.2%	Parkman Healthcare Partners LLC	1,273,789	US$11.6m	24.2%	1.6%
1.14%	Geode Capital Management, LLC	1,209,613	US$11.0m	-1.03%	no data
0.87%	Millennium Management LLC	924,369	US$8.4m	277%	0.01%
0.76%	Decheng Capital LLC	808,789	US$7.4m	-7.01%	1.65%
0.76%	Braidwell LP	802,100	US$7.3m	0%	0.36%
0.55%	Charles Schwab Investment Management, Inc.	579,623	US$5.3m	0%	no data
0.54%	Suvretta Capital Management, LLC	576,156	US$5.3m	-13.2%	0.21%
0.5%	Northern Trust Global Investments	532,099	US$4.9m	4.35%	no data
0.48%	Kaneko Capital, Llc	505,050	US$4.6m	-1.33%	no data
0.44%	Jacobs Levy Equity Management Inc	465,304	US$4.2m	0%	0.02%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/04 02:39
End of Day Share Price	2025/05/02 00:00
Earnings	2024/12/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Arcus Biosciences, Inc. is covered by 16 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Peter Lawson	Barclays
Zhiqiang Shu	Berenberg
Jason Zemansky	BofA Global Research